Search results
26 wrz 2023 · CS was confirmed by histology in all patients from myocardium only (iCS) or extracardiac tissue (nonisolated CS). The primary end point was a composite of mortality, orthotopic heart transplant, and durable left ventricular assist device implantation. CS was isolated in 9 of 50 patients (18%).
16 mar 2023 · The survival graphs reflect the care of cardiac sarcoidosis based on the following principles: requirement of diagnostic histology and pursuit of definite diagnosis, consistent use of corticosteroids with azathioprine and infliximab as the main additional immunomodulators, clinical follow-up with selective instead of routine repeats of positron ...
1 paź 2023 · Cardiac sarcoidosis is a rare but potentially life-threatening condition characterized by the formation of noncaseating granulomas in the myocardium. The diagnosis of cardiac sarcoidosis is challenging because of its diverse and nonspecific clinical presentation.
25 lip 2023 · All‐cause death, HTx, or ventricular arrhythmia occurred in 23 (37%) of 62 patients with de novo CS and 16 (20%) of 79 patients with prior ECS, over a median follow‐up of 61 months (interquartile range, 44–77 months). Among the 62 patients with de novo CS, 1 died, 12 underwent HTx, and 10 had ventricular arrhythmia.
Absolute 10-year risks of outcomes were as follows: HF: 3.18% (95% confidence interval [CI]: 2.83% to 3.57%) for sarcoidosis patients and 1.72% (95% CI: 1.58% to 1.86%) for the background population; the composite of ICD implantation, ventricular arrhythmias, and cardiac arrest: 0.96% (95% CI: 0.77% to 1.18%) for sarcoidosis patients and 0.45% ...
How long can you live with cardiac sarcoidosis? Studies have found that 83% or 93% of people living with cardiac sarcoidosis were alive 10 years later. Survival rates were 80% or higher for one and five years after a heart transplant. Is cardiac sarcoidosis fatal? Yes, cardiac sarcoidosis can be fatal for some people.
26 mar 2015 · The writing group recommended that all patients under the age of 60 years with newly recognized heart block should be screened for cardiac sarcoidosis as this condition is potentially reversible.
